Index

2025

• Single-lead ECGs & AI for rhythm irregularities in general practice
• Prognostic implications of CMR characteristics in primary MR
• Preoperative CMR & echocardiography and post-op LV dysfunction in primary MR
• LV volume ratio & aortic regurgitation severity (Echo & CMR)
• Sex differences in tricuspid regurgitation: a call for awareness
• Age and sex influence on LV remodelling in chronic aortic regurgitation

2024

• Impact of sex on severity assessment and cardiac remodeling in primary MR
• Overcoming lead penetration failure in left bundle branch area pacing
• Additive prognostic value of LV dispersion and deformation in severe AS
• Right atrial cardiac hemangioma: multidisciplinary pathway from symptoms to surgery

2023

• Long-term follow-up after first acute coronary syndrome (French MONICA)
• Quantification of primary MR by echocardiography: a practical appraisal
• Is “moderate” aortic stenosis still the right name? Literature review
• CMR in the assessment of mitral valve prolapse
• Myocardial contraction fraction in significant primary MR
• LA and diastolic dysfunction and mortality in aortic stenosis
• CMR in the assessment of biological aortic valves
• RV-PA coupling in severe AS with preserved EF
• Explainable-AI clustering of primary MR phenotypes
• LDL-C reduction and mortality: systematic review & meta-analysis

2022

• Mitral regurgitant volume: PISA vs volumetric methods
• Significance of LV ejection time in primary MR
• EASI™ 12-lead ECG with handheld device in general practice
• Prosthesis–patient mismatch after bioprosthetic AVR: outcomes
• CMR in native valvular regurgitation: protocols, grading, surgery prediction
• Cardiac damage staging in asymptomatic moderate/severe primary MR
• Semiautomated LV strain and BNP in asymptomatic AS

2021

• Global wasted work in HF receiving CRT
• AT/ET ratio and mortality in high-gradient severe AS
• Caseous necrosis of the mitral annulus (suspected drug-induced VHD)
• Low-flow low-gradient severe AS: definition matters
• Myocardial contraction fraction in low-flow low-gradient AS
• Balloon aortic valvuloplasty before urgent non-cardiac surgery in severe AS

2020

• Pacemaker risk after AVNRT ablation (nationwide cohort)
• Data reuse methodology: from extraction to analysis
• Energy loss index in low-gradient severe AS with preserved EF
• Phenomapping in HF receiving CRT: clinical & prognostic implications
• LV global longitudinal strain and prognosis in severe AS with preserved EF
• Dimensionless Index in low-gradient severe AS with preserved EF

2019

• Prognostic value of low flow in high-gradient severe AS
• Outcome of normal-flow low-gradient severe AS
• Staging cardiac damage in asymptomatic AS
• Moderate AS with preserved EF: prognosis
• Right atrial size and mortality in CRT
• AT/ET ratio and prognosis in low-gradient severe AS with preserved EF
• Correlates of AT/ET ratio in aortic stenosis (Echo & CT)
• Electromechanical dyssynchrony, QRS narrowing and CRT outcome

2018

• Subclinical cardiac dysfunction & extracardiac damage
• Preoperative LV remodelling & long-term outcome after AVR
• Quantitative aortic regurgitation by Doppler
• Secondary MR course in CRT & outcomes

2017

• Left atrial volume & mortality in AS
• Asymptomatic AS: knowledge of patients & GPs
• Peak aortic jet velocity for risk stratification
• Combined score to predict CRT response

2016

• Postoperative QRS widening in CRT
• LV reverse remodeling after CRT
• Echocardiography before CRT (Heart)
• Echocardiography before CRT (Echocardiography)
• WPW & myocardial dyssynchrony
• GLS software upgrade consistency

2015

• Vascular & microvascular endothelial function in HFpEF
• Quantifying MR secondary to MVP by CMR & Echo
• Dimensionless Index & long-term outcome in AS

2014

• Is mechanical dyssynchrony a target in HFpEF?
• Early renal damage in sickle cell disease
• Septal strain & response to CRT
• Speckle-tracking longitudinal strain: inter-constructeurs
• HFpEF : nouvelles pièces du puzzle
• Score combiné pour prédire le remodelage LV après CRT
• FDA criteria for drug-induced valvular heart disease